Nerudia have today announced that they are opening a new office to assist them in serving their US clients across the FMCG, tobacco, vaping and pharmaceutical industries.
The office is located in Reston, Virginia, just 10 minutes from Dulles International airport, giving easy access both internationally and domestically within the US. It is a high-growth tech area which is conveniently located for access to the regulatory agencies and many of the major nicotine industry conferences.
Nerudia are recruiting in both the US and the UK to support their US growth, as the demand for help with PMTA applications increases in light of the new regulations for the vaping industry. They are also working with a number of pharmaceutical customers based in the US who are looking to expand into Europe.
The US office will support and drive business development for all 3 divisions of the Nerudia business – Innovation, Consultancy and Compliance, and UK based supply of e-liquids and base solutions. In the immediate term, all of the testing and laboratory work will continue to be carried out in the UK at Nerudia’s GMP licenced facility.
Andy Gaunt, Nerudia’s Chief Commercial Officer, said “The US is a very important market for Nerudia and we are delighted to be opening an office in Reston. This will benefit us and our US clients, both existing and new, with a much closer day to day relationship in the same time zone. A lot of US clients who worked with us on the TPD regulations for the European side of their business are now turning their attention to the PMTA process, and having a team on the ground will be invaluable as we support and guide them through the complex new regulations.”
For further information please contact firstname.lastname@example.org